Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-08-15 | 5,076 | $2.90 | $14.71kBuy |
Sudarshan Hebbar | Chief Medical Officer | 2025-08-15 | 4,392 | $2.79 | $12.27kBuy |
Sudarshan Hebbar | Chief Medical Officer | 2025-08-14 | 1,584 | $2.59 | $4.09kBuy |
Kenneth A. Stauderman | Chief Scientific Officer | 2025-07-28 | 1,000 | $3.96 | $3.96kBuy |
Kenneth A. Stauderman | Chief Scientific Officer | 2025-07-25 | 1,000 | $3.65 | $3.65kSell |
Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-07-22 | 1,500 | $3.78 | $5.66kBuy |
A. Rachel Leheny | CHIEF EXECUTIVE OFFICER | 2025-07-21 | 1,000 | $3.40 | $3.40kBuy |
Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-07-21 | 1,500 | $3.37 | $5.06kBuy |
Robert N. Wilson | Director | 2025-07-18 | 4,500 | $2.87 | $12.92kBuy |
Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-07-18 | 2,000 | $2.88 | $5.76kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
James E. Flynn | 37.80% | 5,281,713 | $15.54M | Insider |
Orbimed Advisors LLC | 29.80% | 4,163,347 | $12.25M | Insider |
Fred A. Middleton | 22.58% | 3,155,250 | $9.29M | Insider |
Sanderling Venture Partners VI Co Investment Fund LP | 17.23% | 2,407,172 | $7.08M | Insider |
Sanderling Venture Partners VI LP | 16.60% | 2,319,428 | $6.83M | Insider |
Clarus Lifesciences III LP | 13.82% | 1,930,395 | $5.68M | Insider |
Christy L. Shaffer | 11.50% | 1,606,669 | $4.73M | Insider |
Deerfield Management Company LP | 9.30% | 1,300,000 | $3.83M | Institution |
Hansoo Michael Keyoung | 8.11% | 1,133,596 | $3.34M | Insider |
Eric W. Roberts | 7.29% | 1,018,986 | $3.00M | Insider |